An Observational Study of Avastin® (Bevacizumab) in Combination With Chemotherapy for Treatment of First-line Metastatic Colorectal Adenocarcinoma
An Observational Study of Avastin® (Bevacizumab) in Combination With Chemotherapy for Treatment of First-line Metastatic Colorectal Adenocarcinoma
This prospective, multi-center, observational study will assess the safety and efficacy of Avastin (bevacizumab) in daily practice in patients with metastatic colorectal cancer who have received no previous treatment for advanced disease and are receiving Avastin in combination with a standard of care first-line chemotherapy regimen. Data will be collected for 1.5 years or until death.
Inclusion Criteria:
Exclusion Criteria:
Bath, BA1 3NG, United Kingdom
Berkshire, SL2 4HL, United Kingdom
Chelsmford, CM1 7ET, United Kingdom
Peterborough, PE3 9GZ, United Kingdom
Swindon, SN3 6BB, United Kingdom
Winchester, SO22 5DG, United Kingdom